Call our 24 hours, seven days a week helpline at 800.272.3900
Help us end Alzheimer's & Brain Awareness Month with three times the impact. Your gift can be triple-matched, up to $125,000, until June 30 and will help provide much-needed care and support and advance critical research.
There's no cure for Alzheimer’s, but there are treatments that may change disease progression, and drug and non-drug options that may help treat symptoms. Understanding available options can help individuals living with the disease and their caregivers to cope with symptoms and improve quality of life.
Progress in Alzheimer's research has created promising new treatments. Learn about the different drugs so you can discuss the options with a doctor.
Lecanemab (Leqembi™) has received accelerated approval as a treatment for early Alzheimer’s from the U.S. Food and Drug Administration (FDA).
The first FDA-approved therapy to address the underlying biology of Alzheimer’s disease will be discontinued.
Donanemab, a new drug for early Alzheimer’s, significantly slowed progression of the disease in clinical trial results.
CMS has released more details about its plan to cover FDA-approved drugs, including lecanemab, for Alzheimer's disease.
Although current medications cannot cure Alzheimer’s, one treatment addresses the underlying biology. Other medications may help lessen symptoms.
Learn about alternative treatments and the current scientific findings about them.
Donate Now
Take the Brain Tour
Learn More